A Phase III, Multicenter, Randomized, Open-Label Study Evaluating The Efficacy and Safety of MPDL3289A (Anti-PD-L1 Antibody) In Combination with Carboplatin + Nab Paclitaxel For Chemotherapy-Naiive Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer - Regional Cancer Care Associates LLC

Clinical Trials

A Phase III, Multicenter, Randomized, Open-Label Study Evaluating The Efficacy and Safety of MPDL3289A (Anti-PD-L1 Antibody) In Combination with Carboplatin + Nab Paclitaxel For Chemotherapy-Naiive Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer

Type of Cancer
Lung
Locations
Bethesda
Sponsor
F. Hoffmann-La Roche Ltd/Genentech
Protocol Number
GO29537
Cancer Diagnosis
To Learn More Call
201-510-0910